Yuqing Wang Selected Research

Radiotherapy

1/2023	Characterization and mechanisms of radioresistant lung squamous cell carcinoma cell lines.
1/2022	Multisite Radiotherapy Combined With Tislelizumab for Metastatic Castration-Resistant Prostate Cancer With Second-Line and Above Therapy Failure: Study Protocol for an Open-Label, Single-Arm, Phase Ib/II Study.
1/2022	SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer.
1/2021	Hypoxia-Triggered Self-Assembly of Ultrasmall Iron Oxide Nanoparticles to Amplify the Imaging Signal of a Tumor.
1/2021	Downregulation of breast cancer resistance protein by long-term fractionated radiotherapy sensitizes lung adenocarcinoma to SN-38.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuqing Wang Research Topics

Disease

50	Neoplasms (Cancer) 03/2024 - 01/2014
14	Infections 01/2024 - 01/2015
11	Inflammation (Inflammations) 07/2023 - 02/2013
8	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2020
6	Asthma (Bronchial Asthma) 10/2022 - 07/2015
5	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2022
5	Fibrosis (Cirrhosis) 12/2023 - 07/2009
5	Hypoxia (Hypoxemia) 01/2023 - 12/2013
5	Wounds and Injuries (Trauma) 11/2022 - 12/2010
5	Pneumonia (Pneumonitis) 01/2022 - 01/2016
5	Respiratory Sounds (Crackle) 03/2021 - 10/2015
5	Fever (Fevers) 10/2018 - 12/2014
4	Diabetic Foot 01/2024 - 01/2020
4	Hypertension (High Blood Pressure) 12/2023 - 01/2019
4	Colitis 10/2023 - 01/2018
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2018
4	Adenocarcinoma of Lung 01/2023 - 01/2021
4	Ischemia 12/2022 - 09/2021
4	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2021
4	Ulcer 01/2022 - 01/2020
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 10/2010
3	Hyperuricemia 04/2024 - 12/2018
3	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 10/2022
3	Type 2 Diabetes Mellitus (MODY) 03/2024 - 12/2019
3	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2022
3	Tuberculosis (Tuberculoses) 03/2023 - 07/2020
3	Pain (Aches) 01/2023 - 01/2021
3	Obesity 01/2023 - 10/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 05/2021
3	Stomach Neoplasms (Stomach Cancer) 08/2022 - 01/2019
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 12/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
3	Human Influenza (Influenza) 10/2021 - 03/2010
3	Infarction (Infarctions) 09/2021 - 05/2016
3	Virus Diseases (Viral Diseases) 08/2020 - 04/2014
3	Respiratory Syncytial Virus Infections 01/2019 - 01/2015
2	Parkinson Disease (Parkinson's Disease) 03/2024 - 11/2022
2	Unconsciousness (Loss of Consciousness) 12/2023 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 12/2021
2	Bronchitis 09/2023 - 01/2022
2	Reperfusion Injury 08/2023 - 06/2016
2	Ischemic Stroke 08/2023 - 09/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 07/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 07/2023 - 01/2022
2	Glioma (Gliomas) 03/2023 - 12/2021
2	Osteoporosis 01/2023 - 12/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 10/2021
2	Starvation 01/2023 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2022
2	Neuroinflammatory Diseases 01/2023 - 11/2022
2	Infertility (Sterility) 01/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 03/2023 - 07/2015
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2013
7	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2021
5	Peptides (Polypeptides)IBA 03/2024 - 01/2019
5	evodiamineIBA 10/2022 - 12/2021
4	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2021
4	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2014
4	CytokinesIBA 01/2023 - 12/2017
4	Oxygen (Dioxygen)IBA 01/2023 - 12/2013
4	Interleukin-4 (Interleukin 4)IBA 01/2022 - 07/2015
3	Uric Acid (Urate)IBA 04/2024 - 12/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2019
3	LigandsIBA 01/2024 - 07/2017
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2021
3	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2022 - 12/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 02/2013
3	Glutamic Acid (Glutamate)FDA Link 01/2022 - 12/2017
3	Neuroprotective AgentsIBA 01/2022 - 07/2010
3	HydrogelsIBA 12/2021 - 12/2013
3	Therapeutic UsesIBA 12/2021 - 10/2010
3	Contrast MediaIBA 01/2021 - 12/2015
3	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 10/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2020 - 05/2015
3	Protons (Proton)IBA 01/2020 - 02/2013
3	OligopeptidesIBA 12/2019 - 02/2013
2	Blood Glucose (Blood Sugar)IBA 12/2023 - 01/2021
2	CalciumIBA 11/2023 - 12/2019
2	Retinaldehyde (Retinal)IBA 11/2023 - 09/2011
2	Temozolomide (Temodar)FDA LinkGeneric 10/2023 - 12/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2023 - 07/2015
2	PlasticsIBA 09/2023 - 01/2022
2	Imiquimod (Aldara)FDA LinkGeneric 07/2023 - 01/2023
2	Competitive Endogenous RNAIBA 03/2023 - 07/2021
2	Heparin (Liquaemin)FDA LinkGeneric 03/2023 - 12/2016
2	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 01/2023
2	Amino Acids FDA Link 01/2023 - 01/2019

Therapy/Procedure

37	Therapeutics 03/2024 - 10/2016
12	Immunotherapy 03/2024 - 01/2022
9	Drug Therapy (Chemotherapy) 04/2024 - 01/2021
6	Length of Stay 08/2021 - 12/2014
5	Radiotherapy 01/2023 - 01/2021
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 07/2015
3	Lasers (Laser) 01/2023 - 09/2011
3	Injections 01/2023 - 09/2011
3	Surgical Amputation (Amputations) 01/2022 - 01/2020
2	Fecal Microbiota Transplantation 01/2023 - 01/2022